Charles River Laboratories International (CRL) Other Non-Current Liabilities (2009 - 2025)

Charles River Laboratories International (CRL) has reported Other Non-Current Liabilities for 17 consecutive years, with $138.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Other Non-Current Liabilities fell 29.15% year-over-year to $138.3 million; the TTM figure through Dec 2025 stood at $138.3 million (down 29.15% YoY), while the FY2025 annual figure was $138.3 million, down 29.15% from the prior year.
• Other Non-Current Liabilities came in at $138.3 million for Q4 2025 at Charles River Laboratories International, down from $189.5 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $242.9 million in Q4 2021, with the low at $138.3 million in Q4 2025.
• Average Other Non-Current Liabilities over 5 years is $201.8 million, with a median of $195.8 million recorded in 2024.
• Across the five-year window, Other Non-Current Liabilities jumped 37.19% in 2024 and dropped 29.15% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $242.9 million in 2021, then declined by 28.02% to $174.8 million in 2022, then gained by 27.67% to $223.2 million in 2023, then decreased by 12.54% to $195.2 million in 2024, then fell by 29.15% to $138.3 million in 2025.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $138.3 million, $189.5 million, and $185.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.